1-15 of 15
Aibin Liang, MD
Close
Sort by
Journal Articles

Developing a Novel Anti-CD19/CD20 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Relapsed/Refractory (r/r) B-Cell NHL

Lili Zhou, MD, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Shiguang Ye, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Yanfeng Li, MS, Liping Lan, MS, Shicheng Chen, Lin Guo, PhD, Qingsong Zhang, MS, Jiangqin Zheng, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137826
Published: 2020
Journal Articles

Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

Shiguang Ye, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Lili Zhou, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Liping Lan, MS, Shicheng Chen, Yutian Wei, MS, Wangqin Shu, MS, Chen Ye, Dan Zhang, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-138538
Published: 2020
Journal Articles

Good Tolerance and Durable Remission for Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Refractory/Relapsed Mantle Cell Lymphoma

Shiguang Ye, Lili Zhou, Shaoguang Li, Ping Li, Aibin Liang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2818.
https://doi.org/10.1182/blood-2019-129666
Published: 2019
Journal Articles

Role of HDAC8 Upregulation in Resistance of FLT3-ITD AML Stem Cells to FLT3 Inhibitors

Jun Long, Mingyuan Jia, Weiyue Fang, Xinjie Chen, Zhongyu Wang, Lili Mu, Rufang Xiang, Jun-Min LI, MD PhD, Dengli Hong, PhD, Aibin Liang, MD PhD, Jiong Hu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1268.
https://doi.org/10.1182/blood-2019-128394
Published: 2019
Journal Articles

Clinical Presentation, Management and Biomarkers of Cytokine Release Syndrome after Anti-CD19 CART-Cell Therapy for r/r ALL

Ping Li, Lili Zhou, Shiguang Ye, Shaoguang Li, Aibin Liang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5625.
https://doi.org/10.1182/blood-2019-130119
Published: 2019
Journal Articles

FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes

Zonghong Shao, MD, Hui Liu, Hao Jiang, Hongyan Tong, PhD, Ruixiang Xiang, Linhua Yang, Hongguo Zhao, MD, Jian Ouyang, MD, Hai Bai, Hui Sun, Li Hou, Ming Jiang, Zeng Yun, MD PhD, Zhuogang Liu, Aibin Liang, MD PhD, Yinghua Xie, Kang Yu, MD, Zhimin Zhai, MD, Li Liu
Journal: Blood
Blood (2018) 132 (Supplement 1): 3865.
https://doi.org/10.1182/blood-2018-99-116041
Published: 2018
Journal Articles

Hypoxia Potentiates Notch-Induced Expansion of Human Hematopoietic Stem/Progenitor Cells

Jianfei Fu, MD, Heather D. Huntsman, PhD, Ayla Cash, B.Sc., Patali S. Cheruku, B.Sc., Richard H. Smith, PhD, Aibin Liang, MD PhD, Irwin D. Bernstein, MD, Andre Larochelle, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2640.
https://doi.org/10.1182/blood.V128.22.2640.2640
Published: 2016
Journal Articles

IL-10 Contributes to the Development of Immunosuppressive CD14+HLA-DR low/- monocytes in B-Cell Non-Hodgkin’s Lymphoma

Bing Xiu, MD PhD, Yi Lin, MD PhD, Deanna Grote, BA, Steven Ziesmer, Michael Gustafson, PhD, Mary Maas, Zhe Zhang, PhD, Allan B Dietz, PhD, Aibin Liang, MD PhD, Luis F. Porrata, MD, Anne J. Novak, PhD, Zhi-Zhang Yang, MD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2979.
https://doi.org/10.1182/blood.V124.21.2979.2979
Published: 2014
Journal Articles

Genetic and Pharmacologic Targeting Of Alox5 Attenuates JAK2V617F Induced PV In Mice

Yaoyu Chen, MD, PhD, Yi Shan, Zhiru Guo, PhD, Aibin Liang, MD, PhD, Shaoguang Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 112.
https://doi.org/10.1182/blood.V122.21.112.112
Published: 2013
Journal Articles

Alteration of SOCS Is a Possible Pathogenetic Mechanism of Myeloproliferative Neoplasm

Wei Qin, Huina Lu, Jianfei Fu, Aibin Liang, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4121.
https://doi.org/10.1182/blood.V116.21.4121.4121
Published: 2010
Journal Articles

Expression of KDR Plus Detection of Flt3-ITD and NPM1 Mutation as a Prognostic Marker in AML Patients with Normal Karyotype.

Aibin Liang, MD, PhD, Bing Xiu, Binbin Huang, Ying Han, Lanjun Bo
Journal: Blood
Blood (2009) 114 (22): 4715.
https://doi.org/10.1182/blood.V114.22.4715.4715
Published: 2009
Journal Articles

Application of SENP-1, HIF-1α and VEGF Gene Expressions in Prognostic Prediction for Normal Karyotypic Acute Leukemia Patients with NPM1 + and FLT3-ITD - .

Binbin Huang, Bing Xiu, Aibin Liang, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4723.
https://doi.org/10.1182/blood.V114.22.4723.4723
Published: 2009
Journal Articles

A Preliminary Study of Eperythrozoonsis in Shanghai

Aibin Liang, MD, PhD, Congbin Yao, Xiuguo Hua, Congli Yuan
Journal: Blood
Blood (2008) 112 (11): 3459.
https://doi.org/10.1182/blood.V112.11.3459.3459
Published: 2008
Journal Articles

Differential Expression of VEGF and Its Receptors in the Primary Cells of Various Risk Classified Acute Lymphoblastic Leukemia Patients.

Aibin Liang, MD, Li Li, MS, Long-Jun Gu, MD, Hua Jiang, MD, Hui Ye, MD
Journal: Blood
Blood (2004) 104 (11): 4446.
https://doi.org/10.1182/blood.V104.11.4446.4446
Published: 2004
Journal Articles

Higher Expression of Cytochrome-c and Caspase-3 in the Primary Acute Lymphoblastic Leukemic Cells with Negative Expression of VEGF and Its Receptors Than with Positive Expressed Cells under VP16 Induction.

Aibin Liang, MD, Long-Jun Gu, MD
Journal: Blood
Blood (2004) 104 (11): 4448.
https://doi.org/10.1182/blood.V104.11.4448.4448
Published: 2004